Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $5.62 M | -98.61% |
2023 | $0.40 B | -21.9% |
2022 | $0.51 B | -20% |
2021 | $0.64 B | 402.3% |
2020 | $0.12 B | -31.62% |
2019 | $0.18 B | -56.08% |
2018 | $0.42 B | 535.89% |
2017 | $67.44 M | -64.21% |
2016 | $0.18 B | -29.02% |
2015 | $0.26 B | 2.16% |
2014 | $0.25 B | 138.9% |
2013 | $0.10 B |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $0.14 B | $0.60 B | ๐บ๐ธ USA |
Novartis NVS | $30.53 M | $95.22 M | ๐จ๐ญ Switzerland |
Pfizer PFE | $31.87 M | $0.32 B | ๐บ๐ธ USA |
Abbott Laboratories ABT | $62.08 M | $0.14 B | ๐บ๐ธ USA |
Eli Lilly LLY | $50.92 M | $0.12 B | ๐บ๐ธ USA |
Amgen AMGN | $65.7 M | $0.18 B | ๐บ๐ธ USA |
Sanofi SNY | $26.25 M | $54.4 M | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $15.53 M | $26.02 M | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $6.66 M | $42.47 M | ๐ฎ๐ฑ Israel |